Yesterday, HRSA Acting Administrator Diana Espinosa sent letters to Eli Lilly, AstraZeneca, Novartis, Novo Nordisk, Sanofi, and United Therapeutics making clear to the manufacturers that their restrictions on access to…
Drug manufacturer Gilead recently announced that a huge cut in pharmacy reimbursement for its HIV and hepatitis B medicines that uninsured individuals get for free through Gilead’s Advancing Access patient…
On April 6th, 2021, the New York legislature announced that it was delaying a controversial policy that would require the New York Medicaid program to carve out the pharmacy benefit…
Representative Spanberger issued a press release yesterday announcing that she and 225 of her colleagues sent a letter to Acting HHS Secretary Norris Cochran, asking HHS to take immediate action…
The following article was originally published by the Gotham Gazette. Governor Cuomo has worked hard to cultivate a national reputation as the Emmy Award-winning hero of his own covid reality…
The following article was originally posted in Drug Channels on WETM TV 18’s website, https://www.mytwintiers.com, on December 10, 2020. Trillium Health is an RWC-340B Sustaining Member. On December 1, World…
On December 1, 2020, drug manufacturer Novo Nordisk Inc. announced that, effective January 1, 2021, it “will no longer facilitate ‘bill-to/ship-to’ distribution of 340B product to a contract pharmacy of…
Washington, D.C. – On November 23, 2020, Ryan White Clinics for 340B Access (RWC-340B) and five 340B providers filed a motion in the United States District Court for the District…
Thanks to efforts by RWC-340B members and other covered entity advocates, 217 members of the House of Representatives signed a bipartisan letter to Health and Human Services (HHS) Secretary Alex…
By letter dated October 30, 2020, Novartis is notifying covered entities that are federal grantees that they will continue to receive 340B discounts at contract pharmacies and, beginning November 16,…